biopharmaapac.com Open in urlscan Pro
2a02:4780:32:c582:f9b1:ca49:8819:649b  Public Scan

Submitted URL: https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment...
Submission: On May 08 via api from DE — Scanned from DE

Summary

This website contacted 8 IPs in 3 countries across 8 domains to perform 42 HTTP transactions. The main IP is 2a02:4780:32:c582:f9b1:ca49:8819:649b, located in Meppel, Netherlands and belongs to AS-HOSTINGER, CY. The main domain is biopharmaapac.com.
TLS certificate: Issued by R3 on May 6th 2024. Valid for: 3 months.
This is the only time biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

Apex Domain
Subdomains
Transfer
31 biopharmaapac.com
biopharmaapac.com
849 KB
5 google.com
www.google.com — Cisco Umbrella Rank: 2
855 B
2 twitter.com
platform.twitter.com — Cisco Umbrella Rank: 1357
28 KB
1 google-analytics.com
region1.google-analytics.com — Cisco Umbrella Rank: 2533
255 B
1 gstatic.com
www.gstatic.com
203 KB
1 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 39
99 KB
1 youtube.com
www.youtube.com — Cisco Umbrella Rank: 64
1 dripemail2.com
t.dripemail2.com — Cisco Umbrella Rank: 191453
260 B
42 8
Domain Requested by
31 biopharmaapac.com biopharmaapac.com
5 www.google.com biopharmaapac.com
www.gstatic.com
2 platform.twitter.com biopharmaapac.com
platform.twitter.com
1 region1.google-analytics.com www.googletagmanager.com
1 www.gstatic.com www.google.com
1 www.googletagmanager.com biopharmaapac.com
1 www.youtube.com biopharmaapac.com
1 t.dripemail2.com 1 redirects
42 8
Subject Issuer Validity Valid
biopharmaapac.com
R3
2024-05-06 -
2024-08-04
3 months crt.sh
*.google.com
GTS CA 1C3
2024-04-16 -
2024-07-09
3 months crt.sh
*.twimg.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-07-28 -
2024-07-26
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2024-04-16 -
2024-07-09
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2024-04-16 -
2024-07-09
3 months crt.sh

This page contains 7 frames:

Primary Page: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Frame ID: E52577BB849CEBF115B6C671DD27A8E7
Requests: 36 HTTP requests in this frame

Frame: https://www.youtube.com/embed/lOcQEjAN7YU
Frame ID: E33C6140B7A7E150D58E02F70C0A1894
Requests: 1 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Frame ID: D0EA2B6365333A7AE6F2560064F6360A
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=bh3j12jkioiw
Frame ID: F8327976A420D6B84A3D8681B9B027F1
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=iqyqr8wm99y1
Frame ID: E4CF1DB3D10917172E7FAA323D15AE07
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: DBC4AD62E1F4AC3E41B003EC7FA1F792
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 296E25F4E4AFC2517531C76400644A1E
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea

Page URL History Show full URLs

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
    https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-ne... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
  • <link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • //platform\.twitter\.com/widgets\.js

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • /recaptcha/api\.js

Page Statistics

42
Requests

100 %
HTTPS

67 %
IPv6

8
Domains

8
Subdomains

8
IPs

3
Countries

1180 kB
Transfer

2079 kB
Size

6
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1MDg1NTkyLCJuYmYiOjE3MTUwODU1OTIsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiJ1ejd2ZGZxbGJsZ2pzbHA3YjdyaCIsInVybCI6Imh0dHBzOi8vYmlvcGhhcm1hYXBhYy5jb20vbmV3cy84My80NzM5L3NjaXdpbmQtYmlvc2NpZW5jZXMtYW5kLWhrLWlubm8tbi1mb3JnZS1wYXJ0bmVyc2hpcC10by1icmluZy1uZXctZGlhYmV0ZXMtdHJlYXRtZW50LXRvLXNvdXRoLWtvcmVhLmh0bWw_X19zPTVzbHZxZmY2d3YybTdtNmUybDlpJnV0bV9zb3VyY2U9ZHJpcCZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1TY2l3aW5kK0Jpb3NjaWVuY2VzK1RlYW1zK1VwK3dpdGgrSEsraW5uby5OK3RvK1RhY2tsZStEaWFiZXRlcytpbitTb3V0aCtLb3JlYSJ9.M62klAlCTxN7kcnvm49d4BLrbRes8GEesV-rcK4syaM HTTP 307
    https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

42 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html
biopharmaapac.com/news/83/4739/
Redirect Chain
  • https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1MDg1NTkyLCJuYmYiOjE3MTUwODU1OTIsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
  • https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=em...
55 KB
15 KB
Document
General
Full URL
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn / PHP/7.0.33
Resource Hash
7805e99dd8ea6b5616208a83cfe157113bd935b9f1c90d74b87d209e0bc31ae4
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
content-encoding
br
content-security-policy
upgrade-insecure-requests
content-type
text/html; charset=UTF-8
date
Wed, 08 May 2024 01:37:29 GMT
platform
hostinger
server
hcdn
x-hcdn-cache-status
DYNAMIC
x-hcdn-request-id
a514cdd7b56f4fee7117a08486e5c24f-srv-edge5
x-hcdn-upstream-rt
0.890
x-powered-by
PHP/7.0.33

Redirect headers

content-length
0
date
Wed, 08 May 2024 01:37:28 GMT
location
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
bootstrap.min.css
biopharmaapac.com/bundles/taai/app/site/css/
157 KB
21 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/bootstrap.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2582
alt-svc
h3=":443"; ma=86400
content-length
21008
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"27288-658841b5-c558fc44806ec9b6;br"
x-hcdn-request-id
568eb4a9e35296583411fbe1c868677f-srv-edge5
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:54:27 GMT
style.css
biopharmaapac.com/bundles/taai/app/site/css/
25 KB
6 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2582
alt-svc
h3=":443"; ma=86400
content-length
5242
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"6585-658841b5-d7545e5fc4eb3b36;br"
x-hcdn-request-id
ae8880d1115afd989dc2d60c7443f496-srv-edge5
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:54:27 GMT
font-awesome.min.css
biopharmaapac.com/bundles/taai/app/site/css/
20 KB
5 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
4377
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"511e-658841b5-37cf0363bbbb9110;br"
x-hcdn-request-id
feeddf8f922526b67523932b1d592f11-srv-edge5
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
normalize.min.css
biopharmaapac.com/bundles/taai/app/site/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/normalize.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
807
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"897-658841b5-7766ac21e4fe004a;br"
x-hcdn-request-id
0a313b6fc1317edc40819e0553c1e7a9-srv-edge5
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
custom-style.css
biopharmaapac.com/bundles/taai/app/site/css/
342 B
545 B
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/custom-style.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
153
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"156-658841b5-b5014e6d05cc6cea;br"
x-hcdn-request-id
4f5913ce7f210c3032b2df1c9b689279-srv-edge5
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/
5 KB
6 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
aaa9d19086840932772e9956fdb439edd3f6b0e8f591de53ce6d4dbddf1fa633

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2750
x-hcdn-request-id
228a6cdb922942c57c244a0f59272ae2-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
5400
displayad_bioflo320_728x90px_en-58.gif
biopharmaapac.com/uploads/static/
67 KB
67 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/displayad_bioflo320_728x90px_en-58.gif
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
727716580a27f67355a553de8a1ee6c1b0b96e3d31e403c26a50a8d0e38fc57a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
68096
x-hcdn-cache-status
HIT
last-modified
Tue, 30 Apr 2024 07:41:18 GMT
server
hcdn
etag
"10a00-6630a09e-f7360aa79256a458;;;"
x-hcdn-request-id
d113c96795e2b4181a00cdfbafd10144-srv-edge5
content-type
image/gif
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
17247404334195733326-59.jpg
biopharmaapac.com/uploads/static/
15 KB
15 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/17247404334195733326-59.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
f91416ebe951deb0a4fc0a0fcf1be8a096cfa51f77ef083129a80a89a56016c1

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2673
x-hcdn-request-id
0ce9d92b9aa505f286111d0e39e72d75-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
15330
oip-4739.jpg
biopharmaapac.com/uploads/articles/
11 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/articles/oip-4739.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
296c3c66f18dbf6e22573f90bec450ed5fa3e5b437152af5b939d3016ab5995a

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
605
x-hcdn-request-id
b966a21d3cced7b4a6b14c90efcc5b08-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11094
16421605736357482910-2105.png
biopharmaapac.com/uploads/static/
24 KB
24 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/16421605736357482910-2105.png
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
a94ec9082fdaf7a1274e6159c1aada2f7dad7adf2bbddd7033812740af162153

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2673
x-hcdn-request-id
307b2a5e5caa7331967be993998ae2da-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
24572
biotitan_banner_300x250_v_2-61.jpg
biopharmaapac.com/uploads/static/
11 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/biotitan_banner_300x250_v_2-61.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
d7d904e9a98515edf42a248c8cc167fb564c5b9ef545b362027ea4225a9eeb45

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2673
x-hcdn-request-id
3df2a8e1d3bc21d611e06147baecbee8-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11444
biopharma_apac_website_banner_300_x_150_px_2_-64.png
biopharmaapac.com/uploads/static/
11 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/biopharma_apac_website_banner_300_x_150_px_2_-64.png
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
2ea8b83f155a1c7a1b24ef264a3cdc3e0ccf8627d447962adc7168225855b10c

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2673
x-hcdn-request-id
53c51ae73ee26069113a95f5a38d73ae-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11080
unnamed-62.gif
biopharmaapac.com/uploads/static/
36 KB
37 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/unnamed-62.gif
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
461c3cb2d353f837be8a4d1b9ed67e8accdce9af1d69fb0819e9c3d593fb06e0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
37253
x-hcdn-cache-status
HIT
last-modified
Thu, 15 Feb 2024 04:36:58 GMT
server
hcdn
etag
"9185-65cd94ea-254f3b0d30889995;;;"
x-hcdn-request-id
8c47b00c059fa7017a64226425296f65-srv-edge5
content-type
image/gif
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
lOcQEjAN7YU
www.youtube.com/embed/ Frame E33C
0
0
Document
General
Full URL
https://www.youtube.com/embed/lOcQEjAN7YU
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
br
content-type
text/html; charset=utf-8
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
cross-origin-resource-policy
cross-origin
date
Wed, 08 May 2024 01:37:29 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
origin-trial
AmhMBR6zCLzDDxpW+HfpP67BqwIknWnyMOXOQGfzYswFmJe+fgaI6XZgAzcxOrzNtP7hEDsOo1jdjFnVr2IdxQ4AAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTc1ODA2NzE5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma
no-cache
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server
ESF
strict-transport-security
max-age=31536000
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options
nosniff
x-xss-protection
0
14280220722498395040-63.jpg
biopharmaapac.com/uploads/static/
10 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/14280220722498395040-63.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
59be31622cb5372db4b737dfa5f7ff640ef4112b160f1b9d87609633d8ea1514

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2673
x-hcdn-request-id
309babe402e2d479b2d70a15018d937b-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
10606
biopharma_apac_women_s_day_special-4471.jpg
biopharmaapac.com/uploads/articles/
170 KB
171 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/articles/biopharma_apac_women_s_day_special-4471.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
3248ad72ca2f25d3874e6a6dca3ecb489d6484a060287603c7d5e840d8e584c6

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2672
x-hcdn-request-id
ef301cb401613fb925d1181882a9319e-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
174190
screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
biopharmaapac.com/uploads/articles/
53 KB
54 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/articles/screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
05a10bd44e20f26c785b3e4c31295801b9705145585465938c424d9af7bd66af

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2672
x-hcdn-request-id
663ccf53de5c7870881caa803923501d-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
54622
screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
biopharmaapac.com/uploads/articles/
69 KB
70 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/articles/screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
fb58550a82dc1147bd4dd6896f9b37a844ad655377c361757eb9f64c9e732235

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2672
x-hcdn-request-id
6782f9c27575340dfbd2776003b5a60b-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
70900
BPA-Newsletter.jpg
biopharmaapac.com/bundles/taai/app/site/images/
16 KB
17 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/BPA-Newsletter.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
179c2e3f2a72fdfd5273c72316683096c013116f3c94140e1bd9e8571326d039

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2672
x-hcdn-request-id
a2d1dc3ceed0c33511d8e0f90ab3bcc2-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
16642
jquery-3.6.0.min.js
biopharmaapac.com/bundles/taai/app/site/js/
87 KB
30 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/jquery-3.6.0.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
30021
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"15d9d-658841b5-76abcfcbc9734b31;br"
x-hcdn-request-id
ade0e3c46324f18281b215edf7144ef6-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
popper.min.js
biopharmaapac.com/bundles/taai/app/site/js/
21 KB
7 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/popper.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
7193
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"5309-658841b5-f0a1cf827833c88e;br"
x-hcdn-request-id
87c11b78f4cc6ca8e425c01d3688cce1-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
bootstrap.min.js
biopharmaapac.com/bundles/taai/app/site/js/
62 KB
14 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/bootstrap.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
14080
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"f708-658841b5-af11bc98bc815e7d;br"
x-hcdn-request-id
b58b42ece17f8714b05dd725713c1d16-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
jquery.autoscroll.js
biopharmaapac.com/bundles/taai/app/site/js/
1 KB
969 B
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/jquery.autoscroll.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
565
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"59b-658841b5-93f15deffd8af24b;br"
x-hcdn-request-id
0a7b5708c393bcc2579b394231bad229-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
script.js
biopharmaapac.com/bundles/taai/app/site/js/
8 KB
2 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/script.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
1868
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"1ed5-658841b5-3be2fb36bd88fc41;br"
x-hcdn-request-id
0d36eae0c8878b56e7e8dbd56778ee33-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
dips-site-common.js
biopharmaapac.com/bundles/taai/app/site/js/
5 KB
2 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/dips-site-common.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
1639
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"13f4-658841b5-e31a95c6373499c0;br"
x-hcdn-request-id
40db5f4e55f8349be16b47124f598805-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
api.js
www.google.com/recaptcha/
1 KB
855 B
Script
General
Full URL
https://www.google.com/recaptcha/api.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.228 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f4.1e100.net
Software
GSE /
Resource Hash
b4a87969c4cc52d70e75db24b6bda485dbb1beef9ab5c4074e4020176ea1713b
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Wed, 08 May 2024 01:37:29 GMT
widgets.js
platform.twitter.com/
91 KB
28 KB
Script
General
Full URL
https://platform.twitter.com/widgets.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2606:2800:234:59:254c:406:2366:268c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (frb/67AA) /
Resource Hash
173460e89e6a7244218badae2016f65c48a3eae9d400802273eeca18b07336f1

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Wed, 08 May 2024 01:37:29 GMT
Content-Encoding
gzip
Age
211
x-amz-server-side-encryption
AES256
X-Cache
HIT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length
27597
Last-Modified
Mon, 11 Dec 2023 17:20:28 GMT
Server
ECS (frb/67AA)
Etag
"824beb891744db98ccbd3a456e59e0f7+gzip"
Access-Control-Max-Age
3000
Access-Control-Allow-Methods
GET
Content-Type
application/javascript; charset=utf-8
Access-Control-Allow-Origin
*
x-tw-cdn
VZ
Cache-Control
public, max-age=1800
Vary
Accept-Encoding
articulate.min.js
biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/
8 KB
3 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
2410
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"1e7c-658841b5-526d778e2c41316a;br"
x-hcdn-request-id
c6f87e94aa0378367f567e4b10268fae-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
js
www.googletagmanager.com/gtag/
290 KB
99 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
754ee4c59ded4f99081bf6cf547f5fa8d5a6cb6cd91802c8ee69875f011a4473
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
100885
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Wed, 08 May 2024 01:37:29 GMT
back-web.jpg
biopharmaapac.com/bundles/taai/app/site/images/
132 KB
133 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/back-web.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
9807538ba07b58d5a1eeec2c0f131ded66114b057b3f64e56d5e2e9fd7d0ca7a

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2672
x-hcdn-request-id
feb42fbbada4411449e000cae7539d10-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
135608
newsletter-back-Banner.jpg
biopharmaapac.com/bundles/taai/app/site/images/
22 KB
22 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/newsletter-back-Banner.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
add1f3a5245e9a1759b07f6311207675be04b3273de0a142403d44370b3f1876

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2672
x-hcdn-request-id
31e91c8e7a85a95eec0a236634c27d70-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
22080
cd-icon-close.svg
biopharmaapac.com/bundles/taai/app/site/images/
696 B
748 B
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/cd-icon-close.svg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
2673
alt-svc
h3=":443"; ma=86400
content-length
351
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"2b8-658841b5-4ebfd1f75862087e;br"
x-hcdn-request-id
80c28ea0c6d30d6068a825961374a230-srv-edge5
content-type
image/svg+xml
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 00:52:56 GMT
fontawesome-webfont.woff
biopharmaapac.com/bundles/taai/app/site/fonts/
82 KB
82 KB
Font
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/fonts/fontawesome-webfont.woff?v=4.1.0
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:32:c582:f9b1:ca49:8819:649b Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Origin
https://biopharmaapac.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-security-policy
upgrade-insecure-requests
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
age
2672
etag
W/"14730-658841b5-d326144e0621bbb4;;;"
vary
Accept-Encoding
x-hcdn-request-id
da75ae293217bfef17c666f4065479f3-srv-edge5
content-type
application/font-woff
content-encoding
br
x-turbo-charged-by
LiteSpeed
platform
hostinger
alt-svc
h3=":443"; ma=86400
recaptcha__de.js
www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/
509 KB
203 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
352a6d9b12a5ae3949d370ff42a338ba8bb6ff455d9ba995b1755fb7b99e8824
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Origin
https://biopharmaapac.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 07 May 2024 21:15:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
15723
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
207268
x-xss-protection
0
last-modified
Mon, 22 Apr 2024 21:03:35 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Wed, 07 May 2025 21:15:26 GMT
widget_iframe.2f70fb173b9000da126c79afe2098f02.html
platform.twitter.com/widgets/ Frame D0EA
0
0
Document
General
Full URL
https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Requested by
Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2606:2800:234:59:254c:406:2366:268c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (frb/6712) /
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Age
3799797
Cache-Control
public, max-age=315360000
Content-Encoding
gzip
Content-Length
105429
Content-Type
text/html; charset=utf-8
Date
Wed, 08 May 2024 01:37:29 GMT
Etag
"81267302efdfb3e4524a22631a8fc99e+gzip"
Last-Modified
Mon, 11 Dec 2023 17:19:49 GMT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server
ECS (frb/6712)
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Vary
Accept-Encoding
X-Cache
HIT
x-amz-server-side-encryption
AES256
x-tw-cdn
VZ
collect
region1.google-analytics.com/g/
0
255 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-2E2BXNMKP4&gtm=45je4510v877295126za200&_p=1715132249465&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=250411187.1715132250&ul=de-de&sr=1600x1200&uaa=x86&uab=64&uafvl=Chromium%3B124.0.6367.118%7CGoogle%2520Chrome%3B124.0.6367.118%7CNot-A.Brand%3B99.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&frm=0&pscdl=noapi&_s=1&sid=1715132249&sct=1&seg=0&dl=https%3A%2F%2Fbiopharmaapac.com%2Fnews%2F83%2F4739%2Fsciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html%3F__s%3D5slvqff6wv2m7m6e2l9i%26utm_source%3Ddrip%26utm_medium%3Demail%26utm_campaign%3DSciwind%2BBiosciences%2BTeams%2BUp%2Bwith%2BHK%2Binno.N%2Bto%2BTackle%2BDiabetes%2Bin%2BSouth%2BKorea&dt=Sciwind%20Biosciences%20and%20HK%20inno.N%20Forge%20Partnership%20to%20Bring%20New%20Diabetes%20Treatment%20to%20South%20Korea&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=1734
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Wed, 08 May 2024 01:37:29 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://biopharmaapac.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
anchor
www.google.com/recaptcha/api2/ Frame F832
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=bh3j12jkioiw
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.228 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-bKjCpLrHJ2H_gP1MpHOJ8w' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-bKjCpLrHJ2H_gP1MpHOJ8w' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 08 May 2024 01:37:29 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
anchor
www.google.com/recaptcha/api2/ Frame E4CF
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&size=normal&cb=iqyqr8wm99y1
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.228 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce--iYQ9HF9L_GZDFpSK-hZig' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce--iYQ9HF9L_GZDFpSK-hZig' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 08 May 2024 01:37:29 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
favicon.ico
biopharmaapac.com/
1 KB
926 B
Other
General
Full URL
https://biopharmaapac.com/favicon.ico
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
77.37.53.248 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
7428eb0737028b660f7ed162a0e6a8971d9fab47a1954ffd07ab90dce5582bad
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Wed, 08 May 2024 01:37:29 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
446
alt-svc
h3=":443"; ma=86400
content-length
544
x-hcdn-cache-status
HIT
last-modified
Sun, 31 Dec 2023 17:58:04 GMT
server
hcdn
etag
"47e-6591abac-69c23afe33127d87;br"
x-hcdn-request-id
6c8094e5f18f8ac48653ed7ab9040948-srv-edge5
content-type
image/x-icon
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Wed, 15 May 2024 01:30:03 GMT
bframe
www.google.com/recaptcha/api2/ Frame DBC4
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.228 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-4N5euSjjaWf85tDmanU1Jw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-4N5euSjjaWf85tDmanU1Jw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 08 May 2024 01:37:30 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
bframe
www.google.com/recaptcha/api2/ Frame 296E
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=de&v=V6_85qpc2Xf2sbe3xTnRte7m&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/V6_85qpc2Xf2sbe3xTnRte7m/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.228 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-E52iCfphMiGQe0AinREzZw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-E52iCfphMiGQe0AinREzZw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 08 May 2024 01:37:30 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block

Verdicts & Comments Add Verdict or Comment

41 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 function| $ function| jQuery function| Popper object| bootstrap function| fncShow function| fncHide function| pagination function| validateEmail function| allNumeric function| saveEnquiry function| getParameterByName string| passwrodLength function| validatePassword function| validateRegistration function| validateLogin function| validateForgotPassword function| isEmailExist function| validateNewsletter object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| __twttrll object| twttr object| __twttr function| gtag object| dataLayer object| google_tag_manager object| google_tag_data function| onYouTubeIframeAPIReady object| gaGlobal object| recaptcha object| closure_lm_148068

6 Cookies

Domain/Path Name / Value
biopharmaapac.com/ Name: PHPSESSID
Value: pj0nth316srllgij70shsfi261
.youtube.com/ Name: YSC
Value: dfeA2JGs1lE
.youtube.com/ Name: VISITOR_INFO1_LIVE
Value: jaASL2ZMNSk
.youtube.com/ Name: VISITOR_PRIVACY_METADATA
Value: CgJERRIEEgAgRA%3D%3D
.biopharmaapac.com/ Name: _ga_2E2BXNMKP4
Value: GS1.1.1715132249.1.0.1715132249.0.0.0
.biopharmaapac.com/ Name: _ga
Value: GA1.1.250411187.1715132250

1 Console Messages

Source Level URL
Text
recommendation verbose URL: https://biopharmaapac.com/news/83/4739/sciwind-biosciences-and-hk-inno-n-forge-partnership-to-bring-new-diabetes-treatment-to-south-korea.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Sciwind+Biosciences+Teams+Up+with+HK+inno.N+to+Tackle+Diabetes+in+South+Korea
Message:
[DOM] Input elements should have autocomplete attributes (suggested: "current-password"): (More info: https://goo.gl/9p2vKq) %o

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

biopharmaapac.com
platform.twitter.com
region1.google-analytics.com
t.dripemail2.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.youtube.com
100.24.144.132
142.250.184.228
2001:4860:4802:32::36
2606:2800:234:59:254c:406:2366:268c
2a00:1450:4001:809::2008
2a00:1450:4001:81d::2003
2a00:1450:4001:831::200e
2a02:4780:32:c582:f9b1:ca49:8819:649b
77.37.53.248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